These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 21343523)
1. Nerve growth factor eye drop administration improves visual function in a patient with optic glioma. Chiaretti A; Falsini B; Servidei S; Marangoni D; Pierri F; Riccardi R Neurorehabil Neural Repair; 2011 May; 25(4):386-90. PubMed ID: 21343523 [TBL] [Abstract][Full Text] [Related]
2. Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology. Falsini B; Chiaretti A; Barone G; Piccardi M; Pierri F; Colosimo C; Lazzareschi I; Ruggiero A; Parisi V; Fadda A; Balestrazzi E; Riccardi R Neurorehabil Neural Repair; 2011; 25(6):512-20. PubMed ID: 21444653 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective role of nerve growth factor in hypoxicischemic injury. From brain to skin. Chiaretti A; Falsini B; Aloe L; Pierri F; Fantacci C; Riccardi R Arch Ital Biol; 2011 Jun; 149(2):275-82. PubMed ID: 21702000 [TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial. Falsini B; Chiaretti A; Rizzo D; Piccardi M; Ruggiero A; Manni L; Soligo M; Dickmann A; Federici M; Salerni A; Timelli L; Guglielmi G; Lazzareschi I; Caldarelli M; Galli-Resta L; Colosimo C; Riccardi R Brain; 2016 Feb; 139(Pt 2):404-14. PubMed ID: 26767384 [TBL] [Abstract][Full Text] [Related]
5. Incidence and clinical features of ethambutol-induced optic neuropathy in Korea. Lee EJ; Kim SJ; Choung HK; Kim JH; Yu YS J Neuroophthalmol; 2008 Dec; 28(4):269-77. PubMed ID: 19145123 [TBL] [Abstract][Full Text] [Related]
6. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Di Fausto V; Fiore M; Tirassa P; Lambiase A; Aloe L Eur J Neurosci; 2007 Nov; 26(9):2473-80. PubMed ID: 17970722 [TBL] [Abstract][Full Text] [Related]
7. NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study. Falsini B; Iarossi G; Chiaretti A; Ruggiero A; Manni L; Galli-Resta L; Corbo G; Abed E J Transl Med; 2016 Jan; 14():8. PubMed ID: 26748988 [TBL] [Abstract][Full Text] [Related]
8. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of neuroprotective qualities of brimonidine during LASIK. McCarty TM; Hardten DR; Anderson NJ; Rosheim K; Samuelson TW Ophthalmology; 2003 Aug; 110(8):1615-25. PubMed ID: 12917182 [TBL] [Abstract][Full Text] [Related]
10. Significant improvement of visual functions after removal of an intracranial giant optic nerve glioma revealing exophytic growth: case report. Tong Z; Wanibuchi M; Uede T; Tanabe S; Hashi K Neurosurgery; 2006 Apr; 58(4):E792; discussion E792. PubMed ID: 16575300 [TBL] [Abstract][Full Text] [Related]
11. Visual recovery following optic nerve decompression for chronic compressive neuropathy. Bulters DO; Shenouda E; Evans BT; Mathad N; Lang DA Acta Neurochir (Wien); 2009 Apr; 151(4):325-34. PubMed ID: 19255716 [TBL] [Abstract][Full Text] [Related]
12. The early effect of nerve growth factor in the management of serious optic nerve contusion. Zhong Y; Shen X; Liu X; Cheng Y Clin Exp Optom; 2010 Nov; 93(6):466-70. PubMed ID: 20880315 [TBL] [Abstract][Full Text] [Related]
13. [Flash-evoked visual potentials in the early diagnosis of optic nerve injury due to craniofacial fractures]. Altenmüller E; Cornelius CP; Uhl H EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Dec; 22(4):224-9. PubMed ID: 1786783 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Lambiase A; Tirassa P; Micera A; Aloe L; Bonini S Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3800-6. PubMed ID: 16186366 [TBL] [Abstract][Full Text] [Related]
16. Arachnoid cyst of the optic nerve: a case report. Moschos MM; Lymberopoulos C; Moschos M Klin Monbl Augenheilkd; 2004 May; 221(5):408-9. PubMed ID: 15162293 [TBL] [Abstract][Full Text] [Related]
17. Ocular Nerve Growth Factor (NGF) and NGF Eye Drop Application as Paradigms to Investigate NGF Neuroprotective and Reparative Actions. Tirassa P; Rosso P; Iannitelli A Methods Mol Biol; 2018; 1727():19-38. PubMed ID: 29222770 [TBL] [Abstract][Full Text] [Related]
18. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Trisciuzzi MT; Riccardi R; Piccardi M; Iarossi G; Buzzonetti L; Dickmann A; Colosimo C; Ruggiero A; Di Rocco C; Falsini B Clin Neurophysiol; 2004 Jan; 115(1):217-26. PubMed ID: 14706491 [TBL] [Abstract][Full Text] [Related]
19. Oral citicoline treatment improves visual pathway function in glaucoma. Rejdak R; Toczołowski J; Kurkowski J; Kamiński ML; Rejdak K; Stelmasiak Z; Grieb P Med Sci Monit; 2003 Mar; 9(3):PI24-8. PubMed ID: 12640353 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]